Total amount raised
$18 Million
Latest funding date
7/1/2022
Location
Nucleus has successfully navigated three funding rounds, with the most recent being a Series A round supported by 10 investors. The company is backed by 33 investors, including notable names like One Eight Capital and Neo.
Specializing in genetic testing, Nucleus offers advanced services such as IVF+, a preview of future babies, and health tests for over 2000 diseases. Keep reading to explore the intricacies of Nucleus's fundraising journey and the investors backing this innovative platform.
What Is Nucleus?
Nucleus, a genetic testing company based in New York, specializes in uncovering health risks and aiding in reproductive health. The company operates within the biotechnology, health care, and pharmaceutical industries.
Founded with a mission to help families have healthy children, Nucleus employs between 11-50 people. Their services include advanced genetic health tests and IVF+ to support reproductive success.
How Much Funding Has Nucleus Raised?
- Seed Round
- Amount Raised: USD 3,500,000
- Date: December 2021
- Lead Investors: Founders Fund
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand genetic testing capabilities and enhance research and development.
- Seed Round
- Amount Raised: USD 14,000,000
- Date: July 2022
- Lead Investors: Seven Seven Six
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale operations and market reach.
- Series A Round
- Amount Raised: USD 14,000,000
- Date: January 2025
- Lead Investors: Not specified
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To capitalize on the downfall of industry giants and meet the high demand for genetic health innovations.
Total amount raised: USD 31,500,000. Current valuation: Not publicly disclosed.
Key Investors
- Founders Fund
- Details: A venture capital firm known for backing ambitious and often controversial startups.
- Investment Focus Areas: Technology, healthcare, high-impact sectors.
- Notable Investments: Facebook, SpaceX, Palantir Technologies.
- Seven Seven Six
- Details: A venture capital firm founded by Reddit co-founder Alexis Ohanian.
- Investment Focus Areas: Early-stage startups across various sectors.
- Notable Investments: Not publicly disclosed.
- Neo
- Details: An investment firm focusing on early-stage technology companies.
- Investment Focus Areas: Early-stage technology companies.
- Notable Investments: Not publicly disclosed.
- One Eight Capital
- Details: An investment firm involved in the latest funding round for Nucleus.
- Investment Focus Areas: Not publicly disclosed.
- Notable Investments: Not publicly disclosed.
- Giant Step
- Details: An investment firm that participated in the latest funding round for Nucleus.
- Investment Focus Areas: Not publicly disclosed.
- Notable Investments: Not publicly disclosed.
What's Next for Nucleus?
Nucleus stands at the forefront of a rapidly evolving genetic testing market, poised to revolutionize preventative healthcare. By integrating wearable data with genetic insights, the company aims to offer a comprehensive view of personal health. The consumer healthcare market, particularly in genomics and personalized medicine, is projected to exceed $30 billion within the next five years, presenting a vast opportunity for growth.
As the cost of genome sequencing continues to decrease, Nucleus is well-positioned to make genetic testing more accessible and affordable. This growing demand suggests potential for future funding rounds to support further research, development, and market expansion. However, the company must navigate challenges such as ensuring the accuracy of their tests, maintaining consumer trust, and addressing ethical concerns related to genetic data privacy.
Use Clay to Get Funding Data
Sales professionals, take advantage of Clay’s platform to access comprehensive fundraising data on companies like Nucleus and gather other critical business insights.
Sign up for free to start leveraging these powerful tools and stay ahead in your industry.
